Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 388, Issue 11, Pages 969-979
Publisher
Massachusetts Medical Society
Online
2023-03-16
DOI
10.1056/nejmoa2202396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kidney disease and APOL1
- (2021) Aminu Abba Yusuf et al. HUMAN MOLECULAR GENETICS
- A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)
- (2021) Rebecca M. May et al. KIDNEY INTERNATIONAL
- Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity
- (2020) Joseph A Giovinazzo et al. eLife
- APOL1 Nephropathy: From Genetics to Clinical Applications
- (2020) David J. Friedman et al. Clinical Journal of the American Society of Nephrology
- Cation channel conductance and pH gating of the innate immunity factor APOL1 is governed by pore lining residues within the C-terminal domain
- (2020) Charles Schaub et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
- (2020) David Z I Cherney et al. Lancet Diabetes & Endocrinology
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study
- (2019) Christine B. Sethna et al. PEDIATRIC NEPHROLOGY
- Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life
- (2019) Rima S. Zahr et al. HAEMATOLOGICA
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
- (2017) Morten Schmidt et al. BMJ-British Medical Journal
- Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
- (2017) Morten Schmidt et al. BMJ-British Medical Journal
- APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline
- (2015) C. A. Peralta et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects
- (2015) M. G. Sampson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
- (2015) Brendan Nichols et al. KIDNEY INTERNATIONAL
- APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases
- (2015) Opeyemi A. Olabisi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study
- (2014) C. A. Jackevicius et al. BMJ Open
- Rethinking hypertensive kidney disease
- (2013) Jeffrey B. Kopp CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Apolipoprotein L1 Risk Variants Associate with Systemic Lupus Erythematosus-Associated Collapsing Glomerulopathy
- (2013) C. P. Larsen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
- (2013) Afshin Parsa et al. NEW ENGLAND JOURNAL OF MEDICINE
- End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated WithAPOL1
- (2013) Barry I. Freedman et al. Arthritis & Rheumatology
- Treatment of Primary FSGS in Adults
- (2012) S. M. Korbet JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans
- (2012) Michael S. Lipkowitz et al. KIDNEY INTERNATIONAL
- MYH9 and APOL1 are both associated with sickle cell disease nephropathy
- (2011) Allison E. Ashley-Koch et al. BRITISH JOURNAL OF HAEMATOLOGY
- Target Organ Damage in African American Hypertension: Role of APOL1
- (2011) Barry I. Freedman et al. CURRENT HYPERTENSION REPORTS
- APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
- (2011) J. B. Kopp et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans
- (2010) B. I. Freedman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
- (2010) Lawrence J. Appel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
- (2010) G. Genovese et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search